← NewsAll
Anthropic's Claude will soon help interpret Apple Watch health data
Summary
Anthropic launched Claude for Healthcare and is adding beta integrations that let U.S. Claude Pro and Max subscribers connect phone and wearable metrics, including Apple Health, so the assistant can analyze those data. The company says users must opt in, can control permissions, and that health data will not be used to train its models.
Content
Anthropic has introduced Claude for Healthcare, a new set of tools for providers, payers, and patients that the company says will bring AI into medical contexts to help people access and understand health information. In the U.S., subscribers on Claude Pro and Max plans can opt to give the assistant secure access to lab results, records, and wearable metrics. Anthropic is releasing HealthEX and Function connectors in beta and is rolling out Apple Health and Android Health Connect integrations in beta this week through the Claude iOS and Android apps. The company emphasizes user control and privacy features for these integrations.
Key details:
- Claude can summarize medical history, explain test results in simple language, prepare questions for doctor visits, and analyze fitness and wearable metrics such as those from an Apple Watch.
- Anthropic has released HealthEX and Function connectors in beta to let users provide Claude access to medical data.
- Apple Health and Android Health Connect integrations will roll out in beta this week via the Claude app for iOS and Android.
- U.S. subscribers on Claude Pro and Max must explicitly opt in, and they can control, edit, or disconnect the assistant's permissions.
- Anthropic states user health data will not be used to train its AI models, and Claude will include contextual disclaimers and acknowledge areas of uncertainty.
Summary:
Anthropic presents these tools as a way to help users and clinicians review, explain, and spot patterns in health and wearable data. Beta integrations for phone and wearable metrics are rolling out this week; broader availability and clinical use were not detailed. Undetermined at this time.
